载脂蛋白E
认知功能衰退
认知
视网膜
调解
医学
内科学
疾病
血管疾病
痴呆
退行性疾病
心脏病学
阿尔茨海默病
神经科学
心理学
睡眠剥夺对认知功能的影响
认知障碍
内分泌学
载脂蛋白B
认知障碍
内皮
脑淀粉样血管病
血管性痴呆
病理
作者
Yuntao Liu,Hanyu Zhu,Youjie Wang,Xiaoqian Luan,Jiahui Chen,Jiajing Qian,Jianing Shen,Yinhe Liu,Caiyun Wen,Lin Cao,Bo Tang,Ho Ko,William Robert Kwapong,Zhen Wang
摘要
Abstract INTRODUCTION Apolipoprotein E (APOE) ε4 is the strongest genetic risk factor for Alzheimer's disease (AD), with homozygous carriers (ε4/ε4) experiencing accelerated cognitive decline. While its role in amyloid and tau pathology is established, its impact on retinal and cerebral microvasculature remains underexplored. METHODS A total of 107 AD (46 non‐carriers, 42 heterozygotes, 19 homozygotes) underwent optical coherence tomography angiography (OCTA) to assess retinal microvasculature and magnetic resonance imaging (MRI) ‐derived peak width of skeletonized mean diffusivity (PSMD) to evaluate cerebral small vessel disease. Plasma biomarkers (Aβ 42 , p‐tau217, glial fibrillary acidic protein [GFAP], neurofilament light chain [NfL]) and cognitive scores were also analyzed. RESULTS Homozygous APOE ε4 carriers exhibited the most severe reduction in retinal microvascular density and higher PSMD ( p < 0.001). Superficial retinal vessels and PSMD partially mediated APOE ε4's association with cognitive impairment. DISCUSSION APOE ε4 homozygosity exacerbates retinal and cerebral microvascular dysfunction, which partially mediates cognitive impairment in AD. Highlights Apolipoprotein E (APOE) ε4 homozygosity is associated with the most severe reductions in retinal microvascular densities and elevated cerebral small vessel disease (peak width of skeletonized mean diffusivity [PSMD]) in Alzheimer's disease (AD). Vascular dysfunction (retinal and cerebral) correlates with lower Aβ42, higher p‐tau217/Aβ 42 , and worse cognitive scores (Mini‐Mental State Examination [MMSE], Montreal Cognitive Assessment [MoCA]). Mediation analysis reveals that retinal (superficial vascular complex [SVC]) and cerebral (PSMD) microvascular changes partially explain the link between APOE ε4 and cognitive decline. Findings highlight vascular pathways as potential therapeutic targets in APOE ε4 carriers to mitigate cognitive impairment.
科研通智能强力驱动
Strongly Powered by AbleSci AI